It was reported that a patient underwent a redo atrial fibrillation (afib)ablation with a thermocool® smart touch¿ bi-directional navigation catheter and the patient experienced pain caused by a neurostimulator not working post procedure that required additional surgical intervention to get the neurostimulator replaced.In (b)(6)2023, the patient underwent a redo afib procedure.They already had a nuerostimulator implanted within them, a device that was switched off for the procedure per patient guidance.However, after the cardiac ablation occurred the neurostimulator stopped working.Patient was unable to receive pain relief from their neurostimulator since their re-do afib procedure.The pain was initially discovered nearly 4 months after their cardiac ablation procedure.A company representative suspected that the neurotransmitter may have been short-circuited from the radiofrequency (rf) circuit running through the battery pack.However, the cause of the neurotransmitter damage and the patient's subsequent pain has not been confirmed.Although there is no clear causality for the neurotransmitter not working, the possibility of bwi products contributing to the adverse event cannot be excluded.There is no information about the generator.The adverse event is being captured on the ablation catheter as that is what delivers rf ablation and possibly affected the neurostimulator.
|
Note: for section e, there were no initial reporter details provided.Only the country of the event is available.Since no device has been received for analysis, no product investigation can be performed, and the customer complaint cannot be confirmed.Manufacturer record evaluation cannot be conducted because the no lot number was provided by the customer.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by biosense webster, inc., or its employees that the report constitutes an admission that the product, biosense webster, inc.Or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4).
|